BLSM Conversion Disclosure
Orbimed Advisors Llc · SEC Form 4 · Filed Aug 12, 2026
Conversion
Calculated transaction value
$0
Orbimed Advisors Llc Director
BLSM
Transaction date
Aug 10, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 2 days later
BLSM daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series B Preferred Stock on Common Stock
- Quantity / price
- 1,049,283 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0000947871-26-000784
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$10M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Blossomhill Therapeutics, Inc. BLSM | Conversion | Aug 10, 2026 | Not reported |
| Blossomhill Therapeutics, Inc. BLSM | Conversion | Aug 10, 2026 | Not reported |
| Blossomhill Therapeutics, Inc. BLSM | Buy | Aug 10, 2026 | $10M |
| Blossomhill Therapeutics, Inc. BLSM | Conversion | Aug 10, 2026 | $0 |
| Blossomhill Therapeutics, Inc. BLSM Current | Conversion | Aug 10, 2026 | $0 |